A share price of Vaxart Inc [VXRT] is currently trading at $1.27, down -9.29%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VXRT shares have gain 7.63% over the last week, with a monthly amount glided 57.98%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 5, February 2024, Vaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 Challenge. In a post published today on Yahoo Finance, — Data served as foundation for current vaccine candidate for planned Phase 2 research.
From an analyst’s perspective:
Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on November 02, 2021, and set its price target to $15. On June 29, 2021, downgrade downgraded it’s rating to Neutral and revised its price target to $9 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $13 on June 24, 2021. Piper Sandler initiated its recommendation with a Overweight and recommended $18 as its price target on June 11, 2021. H.C. Wainwright reiterated a Buy rating for this stock on August 12, 2020, and upped its price target to $17. In a note dated July 13, 2020, B. Riley FBR initiated an Buy rating and provided a target price of $22 on this stock.
Vaxart Inc experienced fluctuations in its stock price throughout the past year between $0.53 and $1.59. Vaxart Inc [NASDAQ: VXRT] shares were valued at $1.27 at the most recent close of the market.
Analyzing the VXRT fundamentals
Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.1967 points at the first support level, and at 1.1233 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3867, and for the 2nd resistance point, it is at 1.5033.
Vaxart Inc [VXRT] reported earnings per share of -$0.11 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.18/share, meaning a difference of $0.07 and a surprise factor of 38.90%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.16 per share as compared to estimates of -$0.18 per share, a difference of $0.02 representing a surprise of 11.10%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vaxart Inc [NASDAQ:VXRT] is 5.07. In addition, the Quick Ratio stands at 5.07 and the Cash Ratio stands at 0.05. Considering the valuation of this stock, the price to sales ratio is 51.54, the price to book ratio is 2.70.
